HVP – Clinipace Worldwide Closes on $50 Million M&A War Chest
MORRISVILLE, N.C., Jan 15, 2015 (BUSINESS WIRE) –Clinipace Worldwide a global, digital clinical research organization (dCRO) (“Clinipace”), announced today that it has closed a $50 million round of debt and equity financing to capitalize on a pipeline of corporate acquisitions. The financing was led by Virgo Investment Group, LLC (“Virgo”) of Redwood Shores, CA and its investor partners, including Crestline Investors, Inc. Existing investors, including Morgan Stanley Expansion Capital of San Francisco, CA, Hatteras Venture Partners of Durham, NC, Harbert Venture Partners and Mario Family Funds also participated in this most recent round of funding. Perella Weinberg Partners served as advisors to the company.
For the full story, please click here.